Supplier Type
- Manufacturer
- Reagent
- Trader
Supplier Region
- Maharashtra(7)
- Gujarat(12)
- Ahmedabad(9)
- Vadodara(7)
- Karnataka(3)
- New Delhi(1)
- Mumbai(18)
- Uttar Pradesh(1)
- Hyderabad(5)
- Madhya Pradesh(3)
- Delhi(1)
- Kolkata(2)
- Rajasthan(1)
- Nagpur(2)
- Bangalore(1)
- Haryana(1)
Purity
- yes
- Purity
- NLT 99%
- NLT 95%
- more than 90%
- Min.96%
- Min. 35.0%
- Magnesium content 4.0-5.0%
- Greater than 99%
- Chemically pure
- Bismuth Content 56.0 %
- 99.9%
- 99.8%
- 99.6
- 99.50%
- 99.5% to 100.5%
- 99.0%
- 99.0 &100.5
- 99.0 % - 101.0 %
- 99% Pure
- 99%
- >99%
- 99
- 98.5 to 101.5%
- 98.5
- 98.00 % - 102.00 %
- 98.0% to 101.0%
- 98.0% - 102.0%
- 98.0 % - 100.5 %
- 98.0 - 100.5%
- 98% Minimum
- 98%
- >98%
- 97.84%
- 97%
- 97 %
- 96%
- 95% min
- 95%
- >95%
- 93 %- 101%
- >92%
- 90%-95%
- >90%
- 90 % Above
- 86.0 % - 89.0 %
- 80
- 75 %
- 40
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 14.5 - 16.0%
- 100% Pure
- 100%
Package
- 25mg
- 100mg
- 250mg
- 500mg
- 1gm
- 1and gm
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 50mg
- 95NLT %
- 250250 mg.
-
5,6-Dehydro-Tigecycline
1633815-62-9
-
Efavirenz Related Compound C (20 mg) (6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline)
391860-73-4
-
(S)-1-(2-Amino-5-chlorophenyl)-1-(trifluoromethyl)-3-cyclopropyl-2-propyn-1-ol
209414-27-7
-
N-Deethyl DorzolaMide Hydrochloride
164455-27-0
-
1-[(4-Chlorophenyl)phenylmethyl]-4-[(2-methylphenyl)methyl]piperazine
2725237-43-2
-
Imiquimod Related Compound B (25 mg) (1-Isobutyl-1H-imidazo[4,5-c]quinoline 5-oxide)
99010-63-6
-
N-Methylparoxetine
110429-36-2
-
1-(2-METHYLPROPYL)-1H-IMIDAZO[4,5-C]QUINOLINE
99010-24-9
-
7-chloro-1,3-dihydro-5-phenyl-2-oxo-2H-1,4-benzodiazepin-3-yl acetate
1824-74-4
-
N,N'-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide
76820-34-3
Tigecycline 12-oxo-11-hydroxy impurity (USP) 1633815-62-9
DORZOLAMIDE USP RELATED COMPOUND D 164455-27-0
MYTRIACYL EYE DROP 10ML TROPICAMIDE OPHTHALMIC SOLUTION USP 1.0% W/V
Minoxidil (Pyrimidine Diamine Oxide) USP/EP/IP (Kopdil), 38304-91-5 38304-91-5
